Table 2 Differences in the clinical features among those groups classified by FIB-4 Score
From: The correlation between triiodothyronine and the severity of liver fibrosis
Parameters | Q1 | Q2 | Q3 | P values |
|---|---|---|---|---|
Number | 690 | 691 | 691 | Â |
Gender (Male, %) | 404(58.6%) | 415(65.3%) | 404(58.5%) | 0.795 |
Age (Year, Mean ± SD) | 45.13(12.24) | 57.44(10.49) | 64.57(10.94) | < 0.001 |
Hypertension (%) | 205(29.7%) | 319(46.2%) | 374(54.1%) | < 0.001 |
BMI (kg/M2, Mean ± SD) | 24.84(3.90) | 24.75(4.33) | 24.50(3.81) | 0.166 |
Obesity (%) | 121(17.5%) | 113(16.4%) | 109(15.8%) | 0.668 |
Duration (Year, Mean ± SD) | 7.56(2.19) | 8.14(3.96) | 8.20(2.90) | < 0.001 |
TSH (mIU/L, Mean ± SD) | 1.60(0.79) | 1.76(0.93) | 1.81(0.90) | < 0.001 |
fT4 (pmol/L, Mean ± SD) | 17.32(2.19) | 16.57(2.12) | 16.29(2.18) | < 0.001 |
fT3 (pmol/L, Mean ± SD) | 4.68(0.55) | 4.58(0.50) | 4.47(0.50) | < 0.001 |